Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by irreversible scarring. Collagen deposition, myofibroblast expansion, and the development of fibroblastic foci are the hallmark pathological events. The origin and mechanism of recruitment of myofibroblasts, the key cell contributing to these events, is unknown. We hypothesize that the fibrotic lung microenvironment causes differentiation of arriving bone marrow-derived cells into myofibroblasts. Therefore, a method of isolating the effects of fibrotic microenvironment components on various cell types was developed. Electrospun nanofibers were coated with lung extracts from fibrotic or non-fibrotic mice and used to determine effects on bone marrow cells from naïve mice. Varying moduli nanofibers were also employed to determine matrix stiffness effects on these cells. At structured time points, bone marrow cell morphology was recorded and changes in fibrotic gene expression determined by real-time PCR. Cells plated on extracts isolated from fibrotic murine lungs secreted larger amounts of extracellular matrix, adopted a fibroblastic morphology, and exhibited increased myofibroblast gene expression after 8 and 14 days; cells plated on extracts from non-fibrotic lungs did not. Similar results were observed when the nanofiber modulus was increased. This ex vivo system appears to recapitulate the three-dimensional fibrotic lung microenvironment.
Introduction
Tissue engineering is an emerging field that strives to synthesize biologically relevant tissue for a wide range of applications. A number of approaches have been taken to achieve this goal ranging from purely synthetic to purely biological techniques [1e4], each having their own advantages and disadvantages. To overcome limitations associated with a "blank slate" synthetic approach and controversies inherent to any attempt to chemically mimic the in vivo environment that begins with individual biomolecules, we have combined homogenized ex vivo lung tissue with electrospun nanofiber mats. Electrospinning is a well-established procedure for creating three-dimensional (3-D) scaffolds that mimic the in vivo topography although the result often lacks realistic in vivo chemistries. Therefore, we have added homogenized ex vivo fibrotic and normal lung tissue to better recapitulate the chemistry inherent to specific microenvironments and disease states.
By 'borrowing' this tissue engineering technology to address a pathological disease state, we may be able to define new mechanisms of action for interstitial lung diseases, including Idiopathic Pulmonary Fibrosis (IPF). IPF is the most prevalent form of a group of interstitial lung diseases characterized by excessive matrix deposition and destruction of normal lung architecture. The incidence of IPF has more than doubled since 1990, and the disease is almost uniformly fatal, with typical survival of only 2e5 years after diagnosis [5] . While the etiology is unknown, several risk factors have been postulated to lead to the development of IPF, such as smoking, drug exposure, exposure to infectious agents, and genetic predisposition [6, 7] . Although mouse models of pulmonary fibrosis have been utilized to better understand the mechanisms responsible for IPF pathogenesis, currently there are no effective treatments of this disease. Therefore, it is imperative that the molecular mechanisms of IPF pathogenesis are elucidated so that new targets for potential therapeutics may be discovered.
Although little is understood about IPF, it is clear that excessive collagen deposition, myofibroblast expansion, and the development of fibrotic foci are hallmark pathological events [8] . The myofibroblast is the key effector cell that produces collagen and other matrix materials [8] that lead to the loss of alveolar function [9e11] . The origin and mechanism of recruitment of the myofibroblast is unknown, however there are three leading hypotheses. The first hypothesis is that resident fibroblasts differentiate directly in myofibroblasts when exposed to a pro-fibrotic microenvironment [10] . The second hypothesis, termed epithelialemesenchymal transition (EMT), contends that during injury to the lung epithelium, epithelial cells transition into mesenchymal fibroblasts/myofibroblasts. This process continues as the injury to the lung is not resolved, therefore leading to irreversible scarring and loss of normal lung function. This process has been repeatedly demonstrated in vitro, and recent in vivo evidence is accumulating [12e17] . A newer hypothesis proposes that myofibroblasts may be derived from circulating cells known as fibrocytes [18e20]. Discovered in 1994, these cells express type-I collagen and are derived from the bone marrow [21] as indicated by co-expression of CD45. Recent studies have demonstrated that fibrocytes traffic to the lung during injury [8, 22, 23] . However, the mechanisms by which fibrocytes differentiate into myofibroblasts and the origin of these cells are poorly understood. Tissue engineering technologies may allow us to interrogate bone marrow cells to identify the origin of these cells and the gene networks responsible for their expression of matrix-related genes, such as collagen I, which lead to organ fibrosis.
While it is important to study the individual cells responsible for mediating subepithelial lung fibrosis under 'normal' in vitro conditions, in vivo cells exist in a more complex microenvironment. The lung microenvironment is an intricate network of structural (epithelial, fibroblasts, and smooth muscle) and inflammatory (macrophages [24, 25] and neutrophils) cells, cytokines, proteins, and growth factors. An ex vivo system capable of enhancing our understanding of the specific cell and molecular pathways governing the initiation, progression and resolution of pulmonary fibrosis is critical to the development of new diagnostics and therapeutics.
Materials and methods
A 14 wt% solution of poly(e-caprolactone) (PCL) (M n ¼ 70,000e90,000, Sigma) in acetone (Sigma) was prepared by heating acetone to 50 C followed by continuous stirring to dissolve the polymer. The solution was placed in a 60 cc syringe (BD Luer-Lok tip) with a 20 gauge blunt tip needle (EFD, Inc., RI) and electrospun using a high voltage DC power supply (FC50R2, Glassman High Voltage, NJ) set to þ24 kV, a 20 cm tip-tosubstrate distance and a 16 mL/h flow rate. A 3 Â 3" (7.6 Â 7.6 cm) sheet approximately 200 microns (Nanofiber Solutions, Columbus, OH) in thickness was deposited onto nonstick aluminum foil. The resulting 40 g PCL sheets were then placed in a vacuum overnight to ensure removal of residual acetone [26] . High resolution ESI analysis (Esquire) was used to establish that the resulting acetone content is beneath our ability to detect it (less than 10 ppm).
A 8 wt% solution of polyethersulfone (PES) (Goodfellow, Cambridge, UK) in 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) (Sigma) was prepared by continuous stirring within an Erlenmyer flask at room temperature for approximately 12 h to dissolve the PES. The flask was kept tightly stoppered to prevent evaporative losses of HFIP and maintain the desired solids loading. The solution was then placed in a 60 cc syringe (BD Luer-Lok tip) with a 20 gauge blunt tip needle (EFD, Inc., RI) and electrospun using a high voltage DC power supply (FC50R2, Glassman High Voltage, NJ) set to þ23 kV, a 20 cm tip-to-substrate distance and a 5 ml/h flow rate. A 3 Â 3" (7.6 Â 7.6 cm) sheet approximately 0.2 mm in thickness was deposited onto nonstick aluminum foil. The resulting w40 g PES sheets were then placed in a vacuum overnight to ensure removal of residual HFIP [26] .
Core shell fibers [27e30] were prepared by using a 22 gauge hypodermic needle (Integrated Dispensing Solutions Agoura Hills, CA) inserted through a 16 gauge hypodermic T-junction (Small Parts, Inc. Miramar, FL) to create two concentric blunt needle openings. A Swagelok stainless steel union was used to hold the needles in place and ensure the ends of the needles were flush with each other. The core solution of PES þ HFIP was prepared as described above. To optimize the electrospinning of core-shell fibers, the shell solution was prepared using 5 wt% poly(e-caprolactone) dissolved in HFIP by continuous stirring at room temperature. One syringe (BD LuerLok tip) was filled with the polymer solution for the core, PES þ HFIP, connected to the 22 gauge needle and set to a 2 mL/h flow rate using a syringe pump. Another identical syringe was connected via an extension to the T-junction, filled with the shell material, PCL þ HFIP, and set to a flow rate of 2 mL/h using another syringe pump. A high voltage power source (FC50R2, Glassman High Voltage, NJ) was connected to the concentric needle structure and set to þ30 kV for the PES þ HFIP polymer solution core with a shell of PCL þ HFIP and a tip-to-substrate distance of 20 cm. The resulting w40 g sheets were then placed in a vacuum overnight to ensure removal of residual HFIP [26] .
Microstructural characterization
Determination of microstructural change (or its absence) required that these samples be examined in a scanning electron microscope (XL-30 Sirion, FEI, OR). All samples were coated with a 15 nm thick layer of osmium using an osmium plasma coater (OPC-80T, SPI Supplies, West Chester, PA). The use of osmium plasma instead of Au or AuePd eliminated concerns regarding PCL melting during gold sputter coating [31] and allowed for higher resolution imaging [32] of the fiber surface.
Mice and bleomycin regimen
Male mice (FVB/N background), aged 6e12 weeks, underwent intra-peritoneal (IP) injection as previously described [33] . Briefly, mice were injected with 0.035U bleomycin/g or PBS (vehicle control) on days 1, 4, 8, 11, 15, 18, 22, and 25. One week following the last injection, mice were sacrificed. The lungs were removed and solubilized with a glass homogenizer in RPMI 1640 medium supplemented with 5% FBS. The cell suspension was then passed through a 100 mM filter and centrifuged at 1500 rpm for 5 min. The resulting homogenate was resuspended in 1 ml RPMI 1640 medium supplemented with 5% FBS.
Biological effects of lung extract coatings on PCL nanofibers
Nanofiber matrices were spun as previously described and then coated with this bleomycin-treated mouse lung extract [33] using a TC-100 Desktop spin coater (MTI Corporation, CA). Electrospun fiber sheets were cut into 22 mm diameter discs and glued to glass coverslips using 50 mL of an FDA-approved silicone glue (Part# 40076
Applied Silicone Corporation, CA). Separated from it by the electrospun fiber sheet, the cells never made contact with the glue. The fiber discs were then placed on the spin coater at 1000 RPM and pre-wetted with 75 mL of ethanol followed by the immediate addition of 75 mL of the lung extract. After air drying, the extract was lightly cross-linked in place on the fibers as described elsewhere [34] . Briefly, the coated samples were submerged in a 7 mM solution of N-(3-Dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (Part# E1769, SigmaeAldrich) in pure ethanol for 24 h at room temperature. Afterwards, they were rinsed three times using pure ethanol. For comparison purposes, other matrices were spin coated with PBStreated lung extract using exactly the same procedure. All samples were then placed into wells within 12-well cell culture plates, the weight of the glass coverslip being more than sufficient to hold the samples down.
Bone marrow from wild-type FVB/N mice was extracted by passing RPMI Medium 1640 (Gibco-Invitrogen, Carlsbad, CA) through the femur bones into a 15 mL centrifuge tube. The bone marrow was centrifuged at 1500 rpm, and the resulting pellet was resuspended in sterile water to lyse red blood cells. The remaining white blood cells were resuspended in 2 mL RPMI medium. The cells were counted by trypan exclusion and were seeded at densities of 1 Â 10 6 cells/well on top of the fibers in a 12 well plate. 500 mL of RPMI medium supplemented with 5% fetal bovine serum (FBS) was added to each well. Fresh medium was replaced every 3 days. Cells were allowed to proliferate and were harvested at various time-points (2, 4, 8, and 14 days) for scanning electron microscopy and real-time PCR analysis.
Scanning electron microscopy
After various time points, cells and scaffolds were rinsed with PBS 3Â for 5 min each and fixed with a 4% paraformaldehyde aqueous solution for 30 min and then rinsed with an aqueous solution of 0.1 M phosphate buffer þ 0.1 M sucrose for 3Â 5 min. Samples were then dehydrated in a graded ethanol series: 50%EtOH 1Â 5 min, 70% EtOH 1Â 5 min, 80%EtOH 1Â 10 min, 95%EtOH 1Â 10 min, 100%EtOH 2Â 10 min. The samples were then chemically dried using a graded series of 1,1,1,3,3,3-hexamethyldisilazane (HMDS): 3:1 EtOH:HMDS 1Â 15 min, 1:1 EtOH:HMDS 1Â 15 min, 1:3 EtOH:HMDS 1Â15 min, 100%HMDS 2Â 15 min, followed by 100%HMDS allowed to air dry overnight. Samples were then mounted on aluminum pin mounts (Part#16111, Ted Pella, Inc.) using double sided carbon tape (Part#16084-1, Ted Pella, Inc.) and coated with osmium as described earlier for viewing in the SEM.
Real-Time PCR
Total RNA was extracted from cells trypsinized off of the fiber surface using Trizol (Invitrogen, Carlsbad, CA) extractions at various time-points. Reverse Transcription was performed to amplify only mRNA by using oligo-dT primers (Invitrogen, Carlsbad, CA). The resulting cDNA was analyzed by Real-Time PCR with SYBR Green. All primers were designed using Primer Express software (Applied Biosystems, Foster City, CA). Real-Time PCR analysis was done using an ABI 7700 machine (Applied Biosystems, Foster City, CA) with GAPDH as an internal control. Primer sequences: mouse GAPDH: 
Statistical methods
A student's T-test was used to compare cell response. ANOVA was used for multiple comparisons with Tukey's post hoc testing. These analyses were completed using Origin 7.0 (OriginLab, Northrampton, MA). A p-value of less than 0.05 was considered significant for all comparisons.
Results

Biological effects of lung extract coatings on PCL nanofibers
Wild-type mouse bone marrow-derived cells plated on nanofibers coated with lung extracts from PBS or bleomycin-treated mice were fixed and prepared for scanning electron microscopy (SEM) at various time-points. Figs. 1 and 2 reveal minimal differences in the microstructural appearance of plain PCL nanofibers and PCL nanofibers coated with either PBS-or bleomycin-treated lung extract. Cells plated on plain PCL nanofibers and PCL nanofibers coated with PBS-treated lung extracts maintained a rounded appearance, did not form aggregates, and did not appear to secrete matrix materials. However, cells plated on nanofibers coated with bleomycin-treated lung extracts exhibited a spindle-like, fibroblastic morphology, tended to aggregate, and appeared to secrete substantially more matrix after 8 and 14 days (Fig. 3 ). These differences were not apparent at days 2 and 4 in culture (data not shown). Since differences were not observed until 8 days and continued through 14 days, for the remainder of the study cells were cultured for 8 and 14 day time-points. These observations indicated that our ex vivo system induced bone marrow cells to assume a fibroblast-like phenotype in culture.
RNA was isolated from these cells after they were plated on nanofiber matrices coated with lung extracts from either PBS or bleomycin-treated mice. As shown in Fig. 4 , collagen I, alpha smooth muscle actin, and tenascin-C expression were significantly increased in cells plated on nanofibers coated with bleomycin-treated mouse lung extracts versus cells plated on plain PCL nanofibers or PCL nanofibers coated with lung extracts from PBS-treated mice on both days 8 and 14. No significant change in gene expression between the 8 and 14 day time-points. Fibrotic gene expression was not increased relative to PCL on days 2 and 4 (data not shown). This experiment provided significant indications that an appropriately-coated nanofiber matrix could give rise to myofibroblast differentiation signals in bone marrow cells. Current studies are underway in our laboratory to identify the origin of these bone marrow-derived cells.
Biological effects of nanofiber modulus
Cell differentiation and migration occurs in response to mechanical cues, such as matrix stiffness [35e40], from the surrounding microenvironment. In a recent study by Engler and co-workers, mesenchymal stem cells (MSCs) were cultured in matrices of different elasticity (modulus) [41] . Matrices with low modulus differentiated MSCs into neuron-like cells, whereas matrices with high modulus induced MSCs to become myogenic. To establish the role of matrix stiffness independent of lung extract matrix interactions with plated cells, we next tested nanofiber matrices having different moduli spun from synthetic polymers. Bulk polyethersulfone (PES) has a modulus (385,000 psi) w28.5 times greater than that of bulk PCL (13,500 psi). This modification provided a dramatically different modulus appropriate to determining the effects of modulus (if any) on cellular response. We also included a "core-shell" fiber [27e30] consisting of a thin 'shell' of PCL on a 'core' of PES. XPS (Fig. 5 ) was utilized to prove that the PES 'core' was obscured by the PCL as shown by the disappearance of the S2p peak at approximately 170 eV. Core-shell spinning provided an elegant means of retaining the PCL surface chemistry while increasing the overall fiber modulus from 7.1 MPa (pure PCL) to 30.6 MPa, an increase of more than a factor of 4 ( Table 1 ).
Figs. 6 and 7 show that PES core/PCL shell and plain PES possessed limited microstructural differences. However, bone marrow cells plated on PES core/PCL shell nanofibers exhibited a fibroblastic morphology similar to cells plated on PCL with bleomycin-treated extract. These Figs. 6 and 7 also show that culture on uncoated PCL (possessing a modulus used in the initial coating studies) and PES (higher modulus with change in coating) did not affect cell morphology. Mechanical property (modulus, tensile strength) changes (Table 1 ) associated with the presence of the lung extract coatings were not statistically significant. The only statistically significant change observed was a decrease in elongation associated with the bleomycin-treated lung extract coating. However, this difference was observed using strain values many times greater than the bone marrow cells would contact in a fibrotic lung matrix or in the coated native nanofiber matrix. Thus, this observation had little relevance aside from providing another example of how deposition of biologically-generated compounds can lead to restrictions on largescale interfiber translation [42] .
As shown in Fig. 8 , type-I collagen, alpha smooth muscle actin and connective tissue growth factor were increased in cells plated on the core-shell nanofibers compared to both PCL and PES fibers after 8 days in culture. However, tenascin-C was not increased as observed with bleomycin extracted coated fibers. Given that this nanofiber composition has the same surface chemistry as PCL, these results suggested that the nanofiber modulus played a significant role in conditioning the fibrotic response of bone marrow-derived cells. However, after 14 days the core/shell fiber induction of collagen I and SMA expression were diminished while collagen I was increased in cells plated on PES fibers. At 14 days, expression of CTGF and TN-C were increased in cells plated on the core/shell fibers relative to that seen on day 8. Since these fibers did not have a biological coating, it is possible that the changes in gene expression relate to lack of cues in the matrix environment present in the lung extract-coated fiber. These data underscore the importance of both the chemical signals and modulus of the tissue that bone marrow-derived cells encounter in determining their cellular fate in health and disease.
Discussion
For reasons not well understood, mortality rates for idiopathic pulmonary fibrosis continue to climb and have surpassed those from acute myeloid leukemia, multiple myeloma and bladder cancer [43] . There are no available treatments for this disease. No in vitro models exist, making isolation of potential environmental effects difficult. Delineating specific cell and molecular pathways governing the initiation, progression and resolution of IPF [44] is critical to understanding these increases along with enabling development of new diagnostics and therapeutics. Useful in vitro models will allow the study of the impact of the lung microenvironment on the differentiation of circulating bonemarrow derived cells in a manner reminiscent of the in vivo disease state. In our murine model of pulmonary fibrosis [33] , bleomycintreated lungs exhibit increased expression of extracellular matrix components such as collagen I, connective tissue growth factor, asmooth muscle actin and fibronectin relative to PBS-treated mouse lungs. Fibrotic lungs are characterized by increased chemokine content, inflammatory cell infiltration, and increased numbers of myofibroblasts [33] . We hypothesize that this fibrotic milieu causes bone marrow cells to traffic to the lungs and differentiate into myofibroblasts, thus perpetuating the cycle of aberrant woundhealing and irreversible scarring.
The influence of nano-or micro-structures on cellular and intracellular characteristics has been repeatedly demonstrated [45e48] . Electrospinning allows efficient production of nanoscale tissue engineering scaffolds that resemble many of the topographical features of normal ECM. PCL has previously served as an optimal scaffold for cells to adhere to and move freely as they divide and differentiate [4, 26, 42, 49, 50] . We modified this system by coating the nanofibers with bleomycin-(or vehicle-) treated lung extracts. PCL nanofiber scaffolds coated with ex vivo lung extracts caused bone marrowderived cells to differentiate into myofibroblast-like cells. We work with primary bone marrow cells to represent the non-RBC bone marrow environment; cell lines representing individual stem cell types from these tissues have not yet been developed. This system allows us to test our hypothesis that the fibrotic microenvironment may be responsible for the differentiation of bone marrow cells into (myo)fibroblasts in vivo using an ex vivo model. This approach combines biological extracts reminiscent of a specific disease state with synthetic nanofibers that serve as a topographical "blank slate" upon which the specific biochemical characteristics of the disease state can be explored. When bone marrow cells adhered to bleomycin-treated lung extract coatings on electrospun PCL nanofibers, changes in morphology were accompanied by only increases in ECM deposition. In addition, we observed upregulation of genes associated with inflammatory cellular responses relative to PBS-treated controls. In the long-term, this system is particularly powerful in that specific conditions of the matrix can be altered to understand causal events in fibrosis. The addition or subtraction of specific cytokines, growth factors or proteins can be used to determine which of these factors are responsible for myofibroblast differentiation in the chemically complex microenvironment. This model system will allow us to determine which signals present in the fibrotic microenvironment drive differentiation and to develop compounds that either mitigate or reverse this influence. In addition, we can target the bone marrow population that gives rise to myofibroblasts in the lungs of patients with pulmonary fibrosis.
The incidence of IPF is known to increase with age [51] . In parallel, a variety of related fields [52e54] have observed an increase in the stiffness of various tissues with age. The increased condensation of intracellular and extracellular matrix components observed in aged tissues [55] cause an increase in tissue modulus. However, the contribution of these modulus increases, which could conceivably trigger excess scar formation in the lung [51] , to IPF have not yet been elucidated. Bone marrow-derived cells are widely believed to play an important role in mediating inflammation and repair during aging [56e58]. The influence of the modulus of the microenvironment in which they arrive has not, to our knowledge, been previously examined.
To investigate the concept that matrix modulus might play a role in cell differentiation [41] , nanofibers of increasing modulus yet constant surface chemistry were utilized to determine if the bone marrow cells in our study are capable of differentiating into myofibroblast-like cells following adherence to a 'stiffer' matrix. Interestingly, bone marrow-derived cells plated on PCL shell/PES core fiber displayed increased fibrotic gene expression and a morphology similar to cells plated on PCL fibers coated with fibrotic lung extracts. However, cells plated on PES fibers did not exhibit these changes. It is possible that the PES fibers were either too stiff, thus presenting an environment not agreeable to the cells, or possess a specific surface chemistry unfavorable to the inflammatory response. PES is known to encourage stem cell proliferation [59] and this influence may prevent differentiation. Of note, after 14 days in culture the cells plated on core/shell fibers exhibited decreased expression of collagen I and smooth muscle actin. Expression of CTGF and TN-C were increased in cells plated on the core/shell fibers relative to day 8. This could be due to the deposition of biological factors on the "clean slate" of as-spun fiber that generally results in greater cell sensitivities at higher moduli. Previous work [38] has suggested that cells may use different integrin receptors as the stiffness of the matrix is varied and this could be responsible for the observed changes. materials and engineering technology to address other diseases beyond pulmonary fibrosis utilizing the same technology with different tissue extracts (e.g., cirrhotic or solid tumor microenvironments). This platform could allow interrogation of these microenvironments to develop new imaging and high throughput screening technologies to create biologically-inspired next generation materials. This method of testing biomolecular, cellular, and biochemical interactions ex vivo lends itself to agent based modeling approaches making robust cellular pathway development more efficient.
Conclusions
This ex vivo assay focuses on the impact of the lung microenvironment on cell-to-cell and cell-to-matrix interactions resulting in fibrotic lung disease and myofibroblast production. By combining PCL nanofibrous scaffolds with ex vivo lung extracts we demonstrate that 3D geometry and chemical signals provide environmental cues that are necessary for bone marrow cells to acquire a myofibroblast phenotype. Taken together, these observations suggest that bone marrow-derived cells exposed to a fibrotic lung microenvironment develop a more fibroblast/myofibroblast phenotype than cells exposed to a 'normal' lung microenvironment. In addition, the modulus of the underlying nanomatrix plays a significant role in this response. This system can be used to study any disease or organ, not only the lung, rendering it a powerful platform for studying various disease states. This technology also has the potential to be used in the clinic, with tissue extracts from patients used to create a matrix environment representing a disease of interest and then plating human cells onto the matrices as a diagnostic measure. (CPB) and NIH RO1 HL067176 (SNF, CAN, SRW, and CBM). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or the National Institutes of Health. 
